Pharmaceuticals & Healthcare Market Reports

robertjackson5249 un-follow

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets.

Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals Market Report 2017 to 2023

September 19, 2018 01:09PM, 0 comments

19 September 2018: Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that. Systems are making a significant difference in saving lives.

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/pancreatic-cancer-diagnostics-using-artificial-intelligence-for-hospitals-market/request-sample

Much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology. The systems are able to track and analyze more data, more accurately than can the humans. Radiologists receive years of training. They are among the highest paid doctors, also among the first group of physicians utilizing artificial intelligence because of the complexity of the task to be done.

“Artificial intelligence expands into health care leveraging insight from radiological studies and diagnostics. Radiologists have a deluge of patient data that the artificial intelligence can manage in some ways. This contributes to earlier cancer diagnosis.”

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/pancreatic-cancer-diagnostics-using-artificial-intelligence-for-hospitals-market

Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely, while leaving radiologists with more time for interacting with patients and medical staff. Hospital artificial intelligence market shipments at $1.7 billion in 2023 are forecast to reach $11.4 billion dollars, worldwide 2023.

Companies Profiled

Market Leaders

  • General Electric
  • IBM

Market Participants

  • Alphabet / Google
  • GlaxoSmithKline (GSK)
  • Merck
  • Prognos
  • Quest Diagnostics
  • Safeguard Scientifics
  • Zebra

Companies Mentioned

  • Drug discovery artificial intelligence
  • Numerate
  • Exscientia
  • twoXAR
  • Berg
  • Atomwise

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

Immune Checkpoint Inhibitors Market Outlook 2022 : Size, Growth, Industry Share And Forecast Report

September 14, 2018 10:09AM, 0 comments

14 September 2018: Given the wealth of potential targets to overcome tumor-induced immune suppression, many novel active immunotherapies are in clinical development across a range of solid tumor types. The most advanced in development are checkpoint inhibitors. These checkpoint inhibitors have dramatically altered the natural history of hard-to-treat cancers by producing substantial clinical benefits for certain tumor types and patients. Some of these checkpoints are called PD-1, PD-L1, and CTLA-4 receptors. They work by activating the body's immune system against antigens expressed on tumor cells. Drugs that target these checkpoints hold great promise and have generated a tremendous interest in further developing and exploring these strategies across the oncology disease spectrum.

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-immune-checkpoint-inhibitors-market-outlook-2022/request-sample

According to the report “Global Immune Checkpoint Inhibitors Market Outlook 2022”, the global immune checkpoint inhibitors market is anticipated to cross US$ 25 Billion by 2022. The report provides a detailed analysis of the global immune checkpoint inhibitors market. The report also provides the current and forecasted market for immune checkpoint inhibitors.

Furthermore, the report provides insights about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. In addition, the report also highlights various opportunities available for growth of the global immune checkpoint inhibitors market. Moreover, the report provides the sales of commercialized immune checkpoint inhibitors.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-immune-checkpoint-inhibitors-market-outlook-2022

The global immune checkpoint inhibitors market has been segmented on the basis of type of product into PD-1, PD-L1, and CTLA-4. According to the report, PD-1 segment was estimated to account for the largest share in 2016 due to entry of multiple pharmaceutical players in the PD-1 inhibitors market, increasing investments from various key pharmaceutical companies and active research with many pharmaceutical companies looking to launch there products.

On the basis of type of cancer, the immune checkpoint inhibitors market is dominated by Lung Cancer & Melanoma applications with several companies and academic institutions focusing on novel treatment approaches, thus making the major contribution to the global immune checkpoint inhibitors market.

A major focus has been on the ongoing clinical trials for the development of innovative products. In this context, the report provides information about the immune checkpoint inhibitors programs at various stages of clinical development. In addition, the report highlights the strategic collaborations amongst the players for enhancing their market share.

The later part of the report discusses some of the prominent players in the global immune checkpoint inhibitors market. A brief business overview of each player has been provided along with their product and pipeline portfolios and recent developments. Overall, immune checkpoint inhibitor is an important and rapidly emerging field. This report will prove as a complete source of knowledge and analysis for clients and potential investors.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

IoT Platforms for Telemedicine Market 2017 to 2023 : Growth, Industry Share And Analysis Report

September 11, 2018 06:09AM, 0 comments

11 September 2018: IoT platforms for healthcare implement use of the digital economy. IoT for Telemedicine depends on infrastructure scalability excellence, which is achieved with a two layer architecture utilizing adapters and processors to manage sensor connectivity.

Healthcare stakeholders include payers, manufacturers, providers and physicians. Telemedicine IoT platforms provide the technology that implement a framework for transition from disjointed care to coordinated care. Platforms permit clinicians to be reactive to change in patient condition, permitting proactive care delivery.

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/iot-platforms-for-telemedicine-market/request-sample

“Remote healthcare grew 44% in 2016. The Intel Health Application Platform helps enable innovation for greater adoption and effectiveness of secure remote patient care solutions. By offering a platform that supports gathering medical data at the edge of the network, devices are enabled that gather and distribute personal medical data securely to any cloud.”

IoT telemedicine platforms growth is brought by the combination the ability to lower the cost of medical care delivery while improving the quality of care dramatically. The IoT telemedicine platforms value goes beyond traditional medical monitoring bringing to the fore, the value of exercise. The value of exercise has been proven and telemedicine is anticipated to be used by exercise clubs to induce members to do more exercise that is beneficial to long term health. The value of supplemental oxygen in improving endurance and building muscles will likely become a part of telemedicine platform initiatives.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/iot-platforms-for-telemedicine-market

IoT Platforms for Telemedicine market forecast indicates that markets at $1.2 billion in 2016 are expected to reach $9.3 billion dollars worldwide by 2023. These represent a very specialized type of analytics systems able to address a wide range of issues that can be newly managed with digitization. Steady growth is anticipated because the IoT platform units are offering breakthrough digital information integration capabilities that further automates a delivery of care to a patient located remotely. Steady growth is anticipated because the IoT platforms are the best device for implementing efficient operations at low cost.

Companies Profiled

Market Leaders

  • Intel
  • IBM
  • Philips
  • Alibaba
  • Softbank
  • Apple
  • Google
  • Samsung

Market Participants

  • Alphabet / Google
  • Alibaba Group in Shanghai
  • Amazon
  • AMC Health
  • AMD Global
  • American Telehealth Association
  • American Well Systems
  • Apple
  • AT&T
  • Cisco
  • Doctor on Demand
  • GlobalMed
  • Google Chromecast
  • Hewlett HP IoT
  • IBM
  • iHealth Labs
  • Intel IoT Telemedicine Platforms
  • Microsoft IoT
  • Olea Kiosks
  • oneM2M Specifications for IoT Expansion
  • Philips
  • PTC
  • SAP
  • Sensogram Technologies
  • Softbank
  • Symantec / Norton Core Router
  • Teladoc
  • Vivify Health

Companies Mentioned

  • Google, Amazon, Facebook
  • Accenture
  • Qualcomm
  • Niantic Pokémon Go
  • Novartis
  • Apple
  • Push Doctor
  • Babylon
  • McKesson
  • Onduo, a joint venture that Google’s health-care venture, Verily Life Sciences, and Sanofi, a French drug firm
  • Evolution Health
  • Philips
  • Guardant Health
  • Royal Free Hospital in London
  • DeepMind, a British artificial-intelligence (AI) research firm owned by Google
  • GE Healthcare, Siemens, Medtronic
  • Evolution Health
  • Guardant Health

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

Angiography XR Market : Size, Industry Share, Growth, Demand, Forecast And Analysis Report 2018

September 11, 2018 05:09AM, 0 comments

11 September 2018: Angiography XR Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-angiography-xr-market-research-report-2018/request-sample

The report firstly introduced the Angiography XR basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-angiography-xr-market-research-report-2018

The report includes six parts, dealing with:

1.) Basic Information;

2.) Asia Angiography XR Market;

3.) North American Angiography XR Market;

4.) European Angiography XR Market;

5.) Market Entry and Investment Feasibility;

6.) Report Conclusion.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

Blood Glucose Test Strip Market Outlook 2018-2023 : Size, Growth, Industry Share And Forecast Report

September 07, 2018 10:09AM, 0 comments

07 September 2018: Global blood glucose test strip market is anticipated to grow at a CAGR of 6.5% by 2023, according to a new report published by Gen Consulting Company. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-blood-glucose-test-strip-market-outlook-2018-2023/request-sample

The Global Market for blood glucose test strip to 2023 offers detailed coverage of blood glucose test strip industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading blood glucose test strip producers to provide exhaustive coverage of the blood glucose test strip.

Report contents include

- Analysis of the blood glucose test strip market including revenues, future growth, market outlook

- Historical data and forecast

- Regional analysis including growth estimates

- Analyzes the end user markets including growth estimates.

- Profiles on blood glucose test strip including products, sales/revenues, and market position

- Market structure, market drivers and restraints.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-blood-glucose-test-strip-market-outlook-2018-2023

Key Regions

- North America

- Europe

- Asia Pacific

- Middle East and Africa

- South America

Key Vendors

- LifeScan, Inc.

- Abbott Laboratories Inc.

- Panasonic Corporation (Bayer AG)

- ARKRAY, Inc.

- B. Braun Melsungen AG

- Trividia Health, Inc.

- AgaMatrix, Inc.

- request free sample to get a complete list of companies

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

Cystoscope Market Outlook : Size, Industry Share, Growth, Demand, Forecast And Analysis Report 2018

September 05, 2018 10:09AM, 0 comments

Cystoscope Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-cystoscope-market-research-report-2018/request-sample

The report firstly introduced the Cystoscope basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-cystoscope-market-research-report-2018

The report includes six parts, dealing with:

1.) Basic Information;

2.) Asia Cystoscope Market;

3.) North American Cystoscope Market;

4.) European Cystoscope Market;

5.) Market Entry and Investment Feasibility;

6.) Report Conclusion.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

Global, US Gene Therapy Market Forecast to 2020 : Size, Growth, Industry Share And Analysis Report

September 04, 2018 10:09AM, 0 comments

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches are being performed across the globe to explore the potential of gene therapy for the treatment of incurable diseases, such as diabetes, cancer, and HIV amongst others.

According to RNCOS’ new research report "Global & US Gene Therapy Market Forecast to 2020”, most of the gene therapy researches are being focused on finding the treatment for cancer, followed by genetic diseases and neurological disorders, respectively. In this context, the gene therapy application chapter of the report provides a comprehensive overview of various diseases in which the gene therapy is used, along with the current and future market size of gene therapy for particular disease and its geographical break up. Primarily, the gene therapy market is dominated by oncology applications, with several companies and academic institutions focusing on novel and ‘difficult to treat’ cancers. Other therapeutic areas seeking developments in gene therapy include monogenic diseases, cardiovascular diseases, infectious diseases, inherited blindness and neurological diseases. Furthermore, the chapter also provides details regarding the various aspects of the clinical trials in the different gene therapy application by phases, vector types, etc.

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020/request-sample

The major part of the revenue of gene therapy market is generated from research phase. Most of the gene therapy products are in research phases, only few products have been commercialized till date. The report also provides the sales of major marketed gene therapy products, and the list of the products in clinical/pre-clinical research along with their clinical phases.

The companies operating in the gene therapy market are also receiving various funding, grants, and investment from government bodies and venture capitalist firms which are aiding them to develop new products. The study highlights the applications for which the investments have been received.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020

North America continues to have the maximum number of clinical trials in the gene therapy segment. This is a major reason for the dominant position of North America in the gene therapy market. Based on the geography, the market is divided into four regions, namely, North America, Europe, Asia, and Rest of the World. The report provides the market for each of the geography, along with its forecast till 2020.

RNCOS, in its report, further covers how major trends and drivers, mainly gene silencing, advanced therapies combining gene therapy and stem cell technology, immunodeficiency syndromes, growing interest of venture capital firms, etc. will propel the industry’s growth. An analysis has also been done of a few factors limiting the growth of the industry. The report also provides insights regarding the strategies adopted by the players from 2013 to 2015 for enhancing their market share. Finally, with a view to understand the competitive landscape, the profiles of key market players have been included in the report to present a complete picture of the global gene therapy market.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

Combination Antibody Therapy Market 2018-2025 : Share, Industry Analysis, Growth And Forecast Report

August 31, 2018 10:08AM, 0 comments

This report focuses on the global Combination Antibody Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Combination Antibody Therapy development in United States, Europe and China.

Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination antibody drugs are actively focusing on developing superior drugs that will deliver standout results. Factors such as encouraging government policies, growing concerns over higher cancer prevalence worldwide, and increasing research and development activities coupled with heavier investments are expected to boost the overall market growth in the near future. Likewise, healthy R&D pipelines are leading towards higher product offerings and also propelling the growth of global combination antibody therapy market to a significant extent.

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-combination-antibody-therapy-market-size-status-and-forecast-2018-2025/request-sample

The first and foremost reason for fueling the growth of the chemotherapy/antibody segment is the rise in the rates of cancer across the globe. Cancer is the second leading cause of death globally after cardiovascular disease. The proportion of deaths around the world due to cancer has increased remarkably in the last few years.

In 2017, the global Combination Antibody Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

  • Biogen
  • Roche Holdings
  • Seattle Genetics
  • Amgen
  • Bristol-Myers Squibb
  • Eli Lilly
  • Novartis
  • Sanofi
  • Celgene
  • Genmab

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-combination-antibody-therapy-market-size-status-and-forecast-2018-2025

Market segment by Type, the product can be split into

  • Chemotherapy/Antibody
  • Antibody/Antibody
  • Conjugated Antibodies
  • Bispecific Antibodies

Market segment by Application, split into

  • Hospitals
  • Cancer Research Institutes
  • Clinics
  • ASCs

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Combination Antibody Therapy status, future forecast, growth opportunity, key market and key players.
  • To present the Combination Antibody Therapy development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Combination Antibody Therapy are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..

T-Cell Immunotherapy Market for Cancer & Pipeline Analysis : Industry Share And Growth Report

August 28, 2018 11:08AM, 0 comments

Cancer is a class of disease which is classified by an uncontrolled cell growth. There are various types of cancer which are affecting millions of individuals all across the world. According to GLOBOCAN, approximately 15.2 Million incidences of cancer were registered in 2015. This number is forecasted to reach an approximate value of 19.3 Million and 21.6 Million by 2025 and 2030, respectively.

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-t-cell-immunotherapy-market-for-cancer-pipeline-analysis/request-sample

Some of the conventional treatment options for the treatment of cancer are chemotherapy and radiation therapy. Even though these treatment options help in slowing down the progression of the disease, there is no option for the complete eradication of the disease. Moreover, these conventional therapies have numerous side-effects associated with them, such as hair loss, nausea and abnormal blood cell counts. These limitations and adverse effects of conventional therapies have therefore created a significant need for the treatment of cancer with therapies having lesser side effects and better efficacy. One such novel therapy is T-cell Immunotherapy which has shown great promise in the treatment of cancer even in the advanced stages.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-t-cell-immunotherapy-market-for-cancer-pipeline-analysis

According to report on “Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis”, T-cell Immunotherapy is a rapidly expanding field of oncology. This therapy is intended to overcome the challenge of getting the right type of T-cell to the target tumor. It makes use of patients own immune cells to fight cancer. These immune cells are obtained from the patient and genetically engineered before their use for the treatment. Numerous researches are being performed across the globe to explore the potential of T-cell Immunotherapy for the treatment of different types of cancer. During these researches, T-cell Immunotherapies have demonstrated clinical successes on some accounts along with some critical issues on others. Overall, this therapy has emerged as one of the innovative and potent arm of the immunotherapeutic market.

The report provides an in-depth study on the current state of the T-Cell Immunotherapy industry. Recently, the USFDA approved two T-cell Immunotherapies for the treatment of cancer. The approved therapies belong to the class of CAR T-cell Immunotherapies. CAR T-cell therapies are the most researched type of therapy as they have shown exceptional results during clinical trials. The market for such T-cell Immunotherapies is forecasted to grow at an exponential rate owing to the high venture capitalist investments and increasing research related activities in this field.

Furthermore, the global and regional prevalence of major types of cancer for which T-cell Immunotherapy is used is highlighted in the report. These cancers include leukemia, lymphoma, melanoma, ovarian cancer, and bladder cancer amongst others. This will help the companies to gain knowledge regarding the target population for various immunotherapies globally, and at regional level. Moreover, an extensive analysis of the pipeline of T-cell Immunotherapies has been provided in the report. This analysis has been performed on the basis of phases, therapeutic indications, geographies, vectors used, technology types, and key players. This segment also covers the list of the key ongoing clinical trials along with their clinical phases by industry and research collaborations.

The last section of the report discusses about the key players, such as Novartis, Gilead Sciences and Juno Therapeutics among others, in the global T-cell Immunotherapy industry. A brief business overview and financial information about each of these players has been provided in the report. The product portfolio, product pipeline, recent developments and strength-weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of major players. In the end, the areas of opportunities for the growth of this industry have also been highlighted in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global T-cell Immunotherapy market.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:

Michelle Thoras

201 Spear Street 1100, 

Suite 3036, San Francisco, 

CA 94105, United States

Tel: 1-415-349-0054

Toll Free: 1-888-928-9744

Mail: sales@radiantinsights.com

Read more..